Mechanism of action of the suppression of herpes simplex virus type 2 replication by pterocarnin A

被引:56
作者
Cheng, HY
Lin, TC
Yang, CM
Wang, KC
Lin, CC
机构
[1] Kaohsiung Med Univ, Coll Pharm, Grad Inst Pharmaceut Sci, Kaohsiung 807, Taiwan
[2] Tajen Inst Technol, Dept Pharm, Pingtung 907, Taiwan
[3] Kaohsiung Med Univ, Coll Pharm, Grad Inst Nat Prod, Kaohsiung 807, Taiwan
关键词
antiviral activity; HSV-2; ptcrocarnin A; modes of action;
D O I
10.1016/j.micinf.2004.03.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
The purpose of this study was to investigate the in vitro antiviral properties of pterocarnin A. extracted from the bark of Pterocarya stenoptera (Juylandaceae). Results showed that pterocarnin A exhibited anti-herpes simplex virus (HSV) activity. It had a low selectivity index (SI) value and only possessed some level of cell cytotoxic effect at high antiviral concentrations. Mechanism studies demonstrated that pterocarnin A inhibited herpes simplex virus type 2 (HSV-2) from attaching and penetrating into cells. It also actively Suppressed HSV-2 multiplication in Vero cells even when added 12 h after infection. This observation indicated that pterocarnin A affected the late stage(s) of HSV-2 infection cycle. Pterocarnin A also significantly reduced viral infectivity at high concentrations. From these observations, it was concluded that pterocarnin A suppressed both early and late in the replication cycle of HSV-2. The various modes of action of pterocarnin A in interfering, with certain steps of viral infection thus merit further investigation. (C) 2004 Elsevier SAS. All rights reserved.
引用
收藏
页码:738 / 744
页数:7
相关论文
共 43 条
[1]
SCH 43478 and analogs: in vitro activity and in vivo efficacy of novel agents for herpesvirus type 2 [J].
Albin, R ;
Chase, R ;
Risano, C ;
Lieberman, M ;
Ferrari, E ;
Skelton, A ;
Buontempo, P ;
Cox, S ;
DeMartino, J ;
WrightMinogue, J ;
JirauLucca, G ;
Kelly, J ;
Afonso, A ;
Kwong, AD ;
Rozhon, EJ ;
OConnell, JF .
ANTIVIRAL RESEARCH, 1997, 35 (03) :139-146
[2]
New antiherpesvirus agents - Their targets and therapeutic potential [J].
Alrabiah, FA ;
Sacks, SL .
DRUGS, 1996, 52 (01) :17-32
[3]
Antiviral properties of isoborneol, a potent inhibitor of herpes simplex virus type 1 [J].
Armaka, M ;
Papanikolaou, E ;
Sivropoulou, A ;
Arsenakis, M .
ANTIVIRAL RESEARCH, 1999, 43 (02) :79-92
[4]
Incidence of herpes simplex virus type 2 infection in the United States [J].
Armstrong, GL ;
Schillinger, J ;
Markowitz, L ;
Nahmias, AJ ;
Johnson, RE ;
McQuillan, GM ;
St Louis, ME .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (09) :912-920
[5]
Arvin Ann M., 1995, P876
[6]
Identification and characterization of a benzothiophene inhibitor of herpes simplex virus type 1 replication which acts at the immediate early stage of infection [J].
Boulware, SL ;
Bronstein, JC ;
Nordby, EC ;
Weber, PC .
ANTIVIRAL RESEARCH, 2001, 51 (02) :111-125
[7]
Antiherpetic activity and mode of action of natural carrageenans of diverse structural types [J].
Carlucci, MJ ;
Ciancia, M ;
Matulewicz, MC ;
Cerezo, AS ;
Damonte, EB .
ANTIVIRAL RESEARCH, 1999, 43 (02) :93-102
[8]
New therapeutic approaches to the alphaherpesvirus infections [J].
Cassady, KA ;
Whitley, RJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (02) :119-128
[9]
Antiherpes simplex virus type 2 activity of casuarinin from the bark of Terminalia arjuna Linn [J].
Cheng, HY ;
Lin, CC ;
Lin, TC .
ANTIVIRAL RESEARCH, 2002, 55 (03) :447-455
[10]
Survey of resistance of herpes simplex virus to acyclovir in northwest England [J].
Christophers, J ;
Clayton, J ;
Craske, J ;
Ward, R ;
Collins, P ;
Trowbridge, M ;
Darby, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (04) :868-872